Cancer Research Annual Meeting 2010  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 69, 3213, April 1, 2009. Published Online First March 17, 2009;
doi: 10.1158/0008-5472.CAN-08-4223
© 2009 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
0008-5472.CAN-08-4223v1
69/7/3213    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bertout, J. A.
Right arrow Articles by Simon, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bertout, J. A.
Right arrow Articles by Simon, M. C.

Tumor Microenvironment

Heterozygosity for Hypoxia Inducible Factor 1{alpha} Decreases the Incidence of Thymic Lymphomas in a p53 Mutant Mouse Model

Jessica A. Bertout1,2, Shetal A. Patel1,3, Benjamin H. Fryer1, Amy C. Durham2, Kelly L. Covello1, Kenneth P. Olive1, Michael H. Goldschmidt2 and M. Celeste Simon1,3,4

1 Abramson Family Cancer Research Institute, 2 School of Veterinary Medicine, 3 School of Medicine, 4 Howard Hughes Medical Institute, University of Pennsylvania, Philadelphia, Pennsylvania

Requests for reprints: M. Celeste Simon, Howard Hughes Medical Institute, Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, BRB II/III, Room 456, 421 Curie Boulevard, Philadelphia, PA 19104. Phone: 215-746-5532; Fax: 215-746-5511; E-mail: celeste2{at}mail.med.upenn.edu.

Key Words: HIF1{alpha} • HIF2{alpha} • p53 • Notch • thymic lymphoma

Hypoxia inducible factors (HIF) are critical mediators of the cellular response to decreased oxygen tension and are overexpressed in a number of tumors. Although HIF1{alpha} and HIF2{alpha} share a high degree of sequence homology, recent work has shown that the two {alpha} subunits can have contrasting and tissue-specific effects on tumor growth. To directly compare the role of each HIF{alpha} subunit in spontaneous tumorigenesis, we bred a mouse model of expanded HIF2{alpha} expression and Hif1{alpha}+/– mice to homozygotes for the R270H mutation in p53. Here, we report that p53R270H/R270H mice, which have not been previously described, develop a unique tumor spectrum relative to p53R270H/– mice, including a high incidence of thymic lymphomas. Heterozygosity for Hif1{alpha} significantly reduced the incidence of thymic lymphomas observed in this model. Moreover, reduced Hif1{alpha} levels correlated with decreased stabilization of activated Notch1 and expression of the Notch target genes, Dtx1 and Nrarp. These observations uncover a novel role for HIF1{alpha} in Notch pathway activation during T-cell lymphomagenesis. [Cancer Res 2009;69(7):3213–20]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.